Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03635567
Brief Title: Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

First Submitted : August 15, 2018
First Submitted that Met QC Criteria : August 15, 2018
First Posted : August 17, 2018

Last Update Submitted that Met QC Criteria : November 11, 2020
Last Update Posted : November 13, 2020